Although semaglutide is licensed for use only in people with obesity suffering health problems, specialists can legally offer it to anyone they feel might benefit this is known as off-label use
For semaglutide, for example, the initial dose is typically 0.25 mg once a week for the first 4 weeks
Financial considerations: GLP-1s can be expensive, and insurance coverage isnt always reliable
The full prescribing information is available via the electronic medicines compendium
References Teichman SL, Neale A, Lawrence B, et al
Some protocols might also use intramuscular injections (into muscle), though subcutaneous is more common due to better tolerability